Comparison Between Two CRISPR-Cas9 Editing Strategies for Treating Β-thalassemia

β-Thalassemia is a kind of single gene inheritance disease caused by HBB gene mutation. Traditional therapies, like lifelong blood transfusions and iron chelation, impose a heavy burden, while allogenic transplantation is limited by the lack of matched donors. Thus, there is an urgent need for curative ways free from donor availability. CRISPR-Cas9 gene editing offers two pathways: directly correcting the pathogenic HBB mutation by homology-directed repair (HDR) to restore adult hemoglobin (HbA), or disrupting the BCL11A erythroid enhancer through non-homologous end joining (NHEJ) to reactivate fetal hemoglobin (HbF) for functional compensation. This article compares these two strategies in five dimensions: molecular mechanisms, treatment process, clinical evidence, safety risks, and economic costs, and offers an assessment based on literature data and mechanistic analysis. Results show that the BCL11A enhancer editing strategy (exa-cel) has already approved for market use, offering broad applicability, contrary to direct HBB repair offering radical treatment limited by low HDR efficiency in hematopoietic stem cells and the risk of off-target effects involving homologous genes. The latter is mainly in preclinical stage. The article argues that it should put priority to establish the HbF-compensatory approach in short term, whereas long-term efforts should advance the radical treatment. Meanwhile, challenges arouse in balancing efficiency, safety, ethics and accessibility while developing gene editing.

Authors

Publication Details

Journal
Theoretical and Natural Science
Published
2026-11-17
DOI
https://doi.org/10.54254/2753-8818/2027.mb39106
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparison Between Two CRISPR-Cas9 Editing Strategies for Treating Β-thalassemia

Xiwen Liang, Tianmiao Ren
3 links
Theoretical and Natural Science
Hemoglobinopathies and Related Disorders
article

Comparison Between Two CRISPR-Cas9 Editing Strategies for Treating Β-thalassemia

Xiwen Liang, Tianmiao Ren
article en

Abstract

β-Thalassemia is a kind of single gene inheritance disease caused by HBB gene mutation. Traditional therapies, like lifelong blood transfusions and iron chelation, impose a heavy burden, while allogenic transplantation is limited by the lack of matched donors. Thus, there is an urgent need for curative ways free from donor availability. CRISPR-Cas9 gene editing offers two pathways: directly correcting the pathogenic HBB mutation by homology-directed repair (HDR) to restore adult hemoglobin (HbA), or disrupting the BCL11A erythroid enhancer through non-homologous end joining (NHEJ) to reactivate fetal hemoglobin (HbF) for functional compensation. This article compares these two strategies in five dimensions: molecular mechanisms, treatment process, clinical evidence, safety risks, and economic costs, and offers an assessment based on literature data and mechanistic analysis. Results show that the BCL11A enhancer editing strategy (exa-cel) has already approved for market use, offering broad applicability, contrary to direct HBB repair offering radical treatment limited by low HDR efficiency in hematopoietic stem cells and the risk of off-target effects involving homologous genes. The latter is mainly in preclinical stage. The article argues that it should put priority to establish the HbF-compensatory approach in short term, whereas long-term efforts should advance the radical treatment. Meanwhile, challenges arouse in balancing efficiency, safety, ethics and accessibility while developing gene editing.

Theoretical and Natural ScienceVol. 202(1)
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon